Cantimer, Advanced Instruments announce license and product development agreement

Cantimer, Inc., and Advanced Instruments, Inc. today jointly announced that the two companies had signed a license and product development agreement. Under the terms of the license agreement, Advanced Instruments received an exclusive license to Cantimer's unique sensor technology for select applications in the biotech market. The Companies also entered into a Product Development Agreement for Cantimer to develop a specific sensor to integrate into Advanced Instruments' products for in-situ monitoring of osmolality in bioreactors and fermenters. The companies anticipate that a long term sensor supply agreement will follow the joint development effort and that developed products will be sold to end-users through Advanced Instruments' existing commercial network.  

"Monitoring osmolality is a critical control parameter in the biotech market. Traditionally this has been accomplished using discreet samples on a laboratory instrument. Cantimer's unique sensor technology makes it possible to measure osmolality in the bioreactor and in real time, reducing the possibility of product contamination and enabling tighter product quality control" said John Coughlin, CEO of Advanced Instruments. "The industry has been asking for this capability for many years and we believe Cantimer's technology will allow us to finally address their needs" he added.

Cantimer's sensor platform can be adapted to detect and measure a broad array of chemical and biological compounds of interest and has application in markets as large and diverse as life science research, point-of-care diagnostics, consumer health, bio-defense and environmental monitoring. The Company's technology enables the development of simple, portable devices that are robust, sensitive, low-cost, label-free and easy-to-use. In parallel to the development of its own first commercial product, a pocket device for non-invasive measurement and monitoring of changes in human hydration, the Company has undertaken a number of sensor development projects for strategic partners.

"Advanced Instruments has been a very supportive investor and an enthusiastic strategic partner", commented Robin Stracey, CEO of Cantimer, Inc. "We look forward to this joint development effort with great enthusiasm".

Source:

Cantimer, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Wearables and machine learning predict five-year fall risk in Parkinson’s patients